Goldman Sachs Group Inc Genprex, Inc. Transaction History

Goldman Sachs Group Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 May 14, 2024	BUY	$1.28 - $2.31 $27,384 - $49,420	21,394 New	21,394 $30,000
Q2 2022 Aug 15, 2022	SELL	$1.28 - $2.31 $128,229 - $231,413	-100,179 Reduced 82.4%	21,394 $30,000
Q1 2022 May 16, 2022	BUY	$1.82 - $3.5 $180,518 - $347,151	99,186 Added 443.05%	121,573 $275,000
Q4 2021 Feb 14, 2022	BUY	$1.21 - $2.7 $27,088 - $60,444	22,387 New	22,387 $29,000

600

Ticker GNPX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,020,300
Market Cap $76.8M
Description
Genprex, Inc., a clinical-stage gene therapy company, focuses on developing therapies for patients with cancer and diabetes. Its lead product candidate is REQORSA (GPX-001) to treat non-small cell lung cancer and small cell lung cancer. The company is also developing GPX-002, a preclinical stage gene therapy for diabetes. Genprex, Inc. was incor...

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

Stay updated on Goldman Sachs Group Inc with notifications on news.